FindTrial
Sign In

The Study to Evaluate the Effect of marma therapy With an injectival drug(DSCB) in the Management of Gridhrasi (Sciatica).

Comparative Study to Evaluate the Effect of Marma Stimulation With Distal sodium Channel Block (DSCB) in the Management of Gridhrasi (Sciatica). - MARMA and DSCB

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046601
Enrollment
100
Registered
2022-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica Health Condition 2: M543- Sciatica

Interventions

None listed

Sponsors

Dr Anil Kumar Sharma
Lead Sponsor
jaswant singh
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient willing for trial. 2.patient of age group above 18 years with radiating pain in unilateral limb. 3.patient with controlled diabetes.

Exclusion criteria

Exclusion criteria: 1. patient not willing for trial or not ready to give consent 2.patient with infectious diseases of spine. 3.patient with infection at the site of DSCB infiltration. 4. patient with malignancy. 5. pregnant and lactating females. 6.patient with hypersensitivity to the drugs. 7.addicted patients such drug abusers.

Design outcomes

Primary

MeasureTime frame
1.Assessment of duration of pain relief. 2.Assessment of improvement of the range of movement.Timepoint: 01-02 weeks—

Secondary

MeasureTime frame
To assess the quality of lifeTimepoint: 03-04 weeks—

Countries

India

Contacts

Public ContactDr Jaswant Singh

Rajiv Gandhi Govt Post Graduate college and hospital paprola

dranilpaprola@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026